Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy

Background: Glioma, notably glioblastoma multiforme, is characterized by extensive inter-and intra-tumoral heterogeneity. Surprisingly, the potential for differentiation of glioma cells has not been systematically analyzed and included in patient stratification methods. In the current study, retinoi...

Full description

Bibliographic Details
Main Authors: Matthieu Dreyfus, Michèle El-Atifi, Magali Court, Marie Bidart, Charles Coutton, Céline Leclech, Bruno Ballester, Emmanuel Garcion, Ali Bouamrani, François Berger, Didier Wion
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Glioma
Subjects:
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=2;spage=66;epage=78;aulast=Dreyfus
_version_ 1818276303729590272
author Matthieu Dreyfus
Michèle El-Atifi
Magali Court
Marie Bidart
Charles Coutton
Céline Leclech
Bruno Ballester
Emmanuel Garcion
Ali Bouamrani
François Berger
Didier Wion
author_facet Matthieu Dreyfus
Michèle El-Atifi
Magali Court
Marie Bidart
Charles Coutton
Céline Leclech
Bruno Ballester
Emmanuel Garcion
Ali Bouamrani
François Berger
Didier Wion
author_sort Matthieu Dreyfus
collection DOAJ
description Background: Glioma, notably glioblastoma multiforme, is characterized by extensive inter-and intra-tumoral heterogeneity. Surprisingly, the potential for differentiation of glioma cells has not been systematically analyzed and included in patient stratification methods. In the current study, retinoic acid (RA), a neuronal differentiation agent, was assessed for the pro-differentiative and anti-proliferative effects on glioma cells. Methods: Using RA-responsive glioma culture as an experimental paradigm, we analyzed the differentiation process both by videomicroscopy and at the mRNA (RNA-seq and reverse transcription-quantitative-polymerase chain reaction) and proteomic levels. Results: Glioma cells can differentiate into neurons in response to RA by (i) extending ultra-long cytoplasmic extensions, (ii) using these extensions to move from cell to cell either by perikaryal translocation or in a "spider-flight" like process, (iii) slowing their cell cycling, (iv) acquiring several neuronal differentiation markers such as MAPT, GAP43, DCX, NRCAM, NeuroD2, NeuroG2, and NeuN, and (v) decreasing the expression of several genes associated with glioma aggressiveness. Conclusion: These results indicate the existence of a subgroup of patients harboring RA-responsive glioma cells amenable to differentiation therapy, and stratifying such patients with a functional test is easily achievable. This provides the first step to reassess the potential of RA in the context of personalized medicine.
first_indexed 2024-12-12T22:43:30Z
format Article
id doaj.art-871babea5fc9484b8065741c9b662b64
institution Directory Open Access Journal
issn 2589-6113
2589-6121
language English
last_indexed 2024-12-12T22:43:30Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Glioma
spelling doaj.art-871babea5fc9484b8065741c9b662b642022-12-22T00:09:16ZengWolters Kluwer Medknow PublicationsGlioma2589-61132589-61212018-01-0112667810.4103/glioma.glioma_3_18Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapyMatthieu DreyfusMichèle El-AtifiMagali CourtMarie BidartCharles CouttonCéline LeclechBruno BallesterEmmanuel GarcionAli BouamraniFrançois BergerDidier WionBackground: Glioma, notably glioblastoma multiforme, is characterized by extensive inter-and intra-tumoral heterogeneity. Surprisingly, the potential for differentiation of glioma cells has not been systematically analyzed and included in patient stratification methods. In the current study, retinoic acid (RA), a neuronal differentiation agent, was assessed for the pro-differentiative and anti-proliferative effects on glioma cells. Methods: Using RA-responsive glioma culture as an experimental paradigm, we analyzed the differentiation process both by videomicroscopy and at the mRNA (RNA-seq and reverse transcription-quantitative-polymerase chain reaction) and proteomic levels. Results: Glioma cells can differentiate into neurons in response to RA by (i) extending ultra-long cytoplasmic extensions, (ii) using these extensions to move from cell to cell either by perikaryal translocation or in a "spider-flight" like process, (iii) slowing their cell cycling, (iv) acquiring several neuronal differentiation markers such as MAPT, GAP43, DCX, NRCAM, NeuroD2, NeuroG2, and NeuN, and (v) decreasing the expression of several genes associated with glioma aggressiveness. Conclusion: These results indicate the existence of a subgroup of patients harboring RA-responsive glioma cells amenable to differentiation therapy, and stratifying such patients with a functional test is easily achievable. This provides the first step to reassess the potential of RA in the context of personalized medicine.http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=2;spage=66;epage=78;aulast=DreyfusDifferentiation therapygliomapersonalized medicineretinoic acid
spellingShingle Matthieu Dreyfus
Michèle El-Atifi
Magali Court
Marie Bidart
Charles Coutton
Céline Leclech
Bruno Ballester
Emmanuel Garcion
Ali Bouamrani
François Berger
Didier Wion
Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
Glioma
Differentiation therapy
glioma
personalized medicine
retinoic acid
title Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
title_full Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
title_fullStr Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
title_full_unstemmed Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
title_short Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
title_sort reprogramming glioma cell cultures with retinoic acid additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
topic Differentiation therapy
glioma
personalized medicine
retinoic acid
url http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=2;spage=66;epage=78;aulast=Dreyfus
work_keys_str_mv AT matthieudreyfus reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT micheleelatifi reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT magalicourt reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT mariebidart reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT charlescoutton reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT celineleclech reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT brunoballester reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT emmanuelgarcion reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT alibouamrani reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT francoisberger reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy
AT didierwion reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy